EDMONTON, (June 21, 2016) – MagnetTx Oncology Solutions, Inc. (“MagnetTx” or the “Company”) is pleased to announce that it has secured worldwide, exclusive rights from Alberta Health Services and the University of Alberta to commercialize breakthrough technology that combines magnetic resonance (MR) imaging and linear accelerator technology for radiation treatment required by cancer patients.
MagnetTx secures worldwide license rights to develop and commercialize novel MR imaging and linear accelerator technology for cancer
Come see us in the Exhibit Hall, Booth #2085, at the American Society for Radiation Oncology (ASTRO) 58th Annual Meeting in Boston, MA. The Exhibit Hall is open from 10 AM to 5 PM, September 25 to 27, 2016.
The unique patented design of the Aurora RT™ has been optimized and refined by the Linac MR Research group at the Cross Cancer Institute in Edmonton, Alberta Canada. This group started the Advanced Real Time Adaptive Radio Therapy (ART2) program in 2005 to take on the challenge of combining the proven cancer treatment capabilities of a Linear Accelerator with the soft tissue imaging capabilities of Magnetic Resonance Imaging.
This research is documented in the companion scientific website:
The peer reviewed scientific publications can be found here.
Works-in-Progress Not Currently for Sale
Aurora RT™ is an integrated medical linear accelerator and MR Imager for precise treatment set-up and for simultaneous treatment with soft-tissue imaging. This device uses a unique patented design which almost totally eliminates the interference between the Linac and the MR. Specifically, the magnetic field of the MR unit is provided by a cryogen free bi-planar magnet which rotates. The linac is oriented to be parallel to the magnetic field of the MR unit. The radiation beam is directed through the center of the coils along their common axis, and the entire system rotates together.
MagnetTx Oncology Solutions has been formed to commercialize the Linac-MR technology developed at the University of Alberta and Cross Cancer Institute in Edmonton, Alberta Canada. The company has been founded by the inventors – Dr. Gino Fallone and Brad Murray. MagnetTx Oncology Solutions has exclusive rights to negotiate an agreement to license the Linac-MR Technology from Alberta Health Services. The team at the Cross Cancer Institute was the first in the world to show proof of principle in 2008 when they produced MR images concurrently with linac radiation. Subsequently, they have developed a clinical prototype that is currently installed at the Cross Cancer Institute. This will be the basis of the commercial system called the “Aurora RT”.
MR imaging is well known for its exquisite soft tissue contrast. State of the art linear accelerators have Cone Beam CT (CBCT) image guidance, which suffers from low contrast, and CT images cannot be captured concurrently with the beam delivery. The Aurora RT™ combines high quality MR images with a 6 MV linear accelerator. The machine is designed to provide excellent images prior to treatment for accurate patient alignment, as well as real time MR imaging during beam delivery to allow advance gating or tumour tracking features. These also make the Aurora RT™ perfectly suited for adaptive radiotherapy.
|Linac Energy||6 MV|
|MultiLeaf Collimator (MLC)||120 Leaves (standard, micro)|
|Patient Opening||110 cm W x 60 cm H|
|Linac_MR Configuration||Aligned - Rotate Together|
|MR Position||Rotates 360 degrees|
|Beam-Orientation||Parallel to Magnetic Field (minimal dosimetric perturbation)|
|Bunker and Maze Size||Standard for Linacs (installation through maze)|
|MR Cryogens and Venting||None Required|
|Beam Modulation||IMRT, VMAT|
|Soft-tissue Imaging Rate||Four images per sec|
|Treatment Planning||Real-time Adaptive|